MG
NTUS

Michael Gelband’s Natus Medical Inc NTUS Stock Holding History

Michael Gelband’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,194
Closed -$256K – 2781
2021
Q3 		$256K Sell
10,194
-25,893
-72% -$660K ﹤0.01% 1683
2021
Q2 		$938K Buy
+36,087
New +$982K 0.01% 1047
2021
Q1 		– Sell
-93,276
Closed -$1.87M – 2780
2020
Q4 		$1.87M Buy
93,276
+78,782
+544% +$1.54M 0.02% 563
2020
Q3 		$248K Buy
+14,494
New +$274K ﹤0.01% 1376

Other funds holding NTUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Michael Gelband's NTUS Position: Q4 2021 in Review

Michael Gelband sold out of Natus Medical Inc (NTUS) in Q4 2021, closing a stake of 10,194 shares — an estimated $256K sold.

Michael Gelband first reported a position in NTUS in Q3 2020 and held it in 4 quarters. The position peaked at $1.87M in Q4 2020. 172 funds tracked by Wall St. Rank hold NTUS as of Q4 2021.

  • Michael Gelband reported no remaining Natus Medical Inc position as of Q4 2021 after selling out during the quarter.
  • Michael Gelband sold 10,194 Natus Medical Inc shares in Q4 2021, an estimated $256K.
  • Michael Gelband first reported a position in Natus Medical Inc in Q3 2020 and held it in 4 quarters.
  • Michael Gelband's Natus Medical Inc position peaked at $1.87M in Q4 2020.
  • 172 funds tracked by Wall St. Rank held Natus Medical Inc as of Q4 2021.

Based on ExodusPoint Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.